Cargando…

Progressive familial intrahepatic cholestasis: diagnosis, management, and treatment

Progressive familial intrahepatic cholestasis (PFIC) is a group of autosomal recessive cholestatic liver diseases which are subgrouped according to the genetic defect, clinical presentation, laboratory findings and liver histology. Progressive liver fibrosis, cirrhosis, and end stage liver disease (...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunaydin, Mithat, Bozkurter Cil, Asudan Tugce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136920/
https://www.ncbi.nlm.nih.gov/pubmed/30237746
http://dx.doi.org/10.2147/HMER.S137209
_version_ 1783355091633307648
author Gunaydin, Mithat
Bozkurter Cil, Asudan Tugce
author_facet Gunaydin, Mithat
Bozkurter Cil, Asudan Tugce
author_sort Gunaydin, Mithat
collection PubMed
description Progressive familial intrahepatic cholestasis (PFIC) is a group of autosomal recessive cholestatic liver diseases which are subgrouped according to the genetic defect, clinical presentation, laboratory findings and liver histology. Progressive liver fibrosis, cirrhosis, and end stage liver disease (ESLD) may eventually develop. PFIC was first described in Amish descendants of Jacob Byler, therefore it was originally called Byler disease. But it can be seen anywhere on the globe. This review summarizes the main features of the subtypes of the disease and discusses the current available diagnosis, conservative and surgical therapeutic options.
format Online
Article
Text
id pubmed-6136920
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-61369202018-09-20 Progressive familial intrahepatic cholestasis: diagnosis, management, and treatment Gunaydin, Mithat Bozkurter Cil, Asudan Tugce Hepat Med Review Progressive familial intrahepatic cholestasis (PFIC) is a group of autosomal recessive cholestatic liver diseases which are subgrouped according to the genetic defect, clinical presentation, laboratory findings and liver histology. Progressive liver fibrosis, cirrhosis, and end stage liver disease (ESLD) may eventually develop. PFIC was first described in Amish descendants of Jacob Byler, therefore it was originally called Byler disease. But it can be seen anywhere on the globe. This review summarizes the main features of the subtypes of the disease and discusses the current available diagnosis, conservative and surgical therapeutic options. Dove Medical Press 2018-09-10 /pmc/articles/PMC6136920/ /pubmed/30237746 http://dx.doi.org/10.2147/HMER.S137209 Text en © 2018 Gunaydin and Bozkurter Cil. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Gunaydin, Mithat
Bozkurter Cil, Asudan Tugce
Progressive familial intrahepatic cholestasis: diagnosis, management, and treatment
title Progressive familial intrahepatic cholestasis: diagnosis, management, and treatment
title_full Progressive familial intrahepatic cholestasis: diagnosis, management, and treatment
title_fullStr Progressive familial intrahepatic cholestasis: diagnosis, management, and treatment
title_full_unstemmed Progressive familial intrahepatic cholestasis: diagnosis, management, and treatment
title_short Progressive familial intrahepatic cholestasis: diagnosis, management, and treatment
title_sort progressive familial intrahepatic cholestasis: diagnosis, management, and treatment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136920/
https://www.ncbi.nlm.nih.gov/pubmed/30237746
http://dx.doi.org/10.2147/HMER.S137209
work_keys_str_mv AT gunaydinmithat progressivefamilialintrahepaticcholestasisdiagnosismanagementandtreatment
AT bozkurtercilasudantugce progressivefamilialintrahepaticcholestasisdiagnosismanagementandtreatment